注册以创建品种、
财经事件和所关注作者内容的提醒
免费注册 已有账户? 登录
Anixa Biosciences Inc是一家生物技术公司。该公司主要从事开发疫苗和疗法,专注于肿瘤学和传染病领域未满足的关键需求。该公司的业务部门包括CAR-T疗法、癌症疫苗、抗病毒疗法和其他。其疫苗计划包括开发针对三阴性乳腺癌(TNBC)的预防性疫苗、致命形式的乳腺癌以及其他形式的乳腺癌,以及开发针对卵巢癌的预防性疫苗。该公司治疗项目包括开发嵌合内分泌受体T细胞疗法,这是一种专注于治疗卵巢癌的嵌合抗原受体T细胞 (CAR-T) 技术,由该公司的子公司Certainty Therapeutics, Inc开发, 以及用于治疗COVID-19的抗病毒候选药物的开发重点是抑制病毒的某些蛋白质功能。
名称 | 年龄 | 任期 | 标题 |
---|---|---|---|
Daniel Abate-Daga | - | 2018 | Member of Scientific Advisory Board |
H. Michael Shepard | - | - | Member of Scientific Advisory Board |
Linda L. Kelley | 68 | 2018 | Member of Scientific Advisory Board |
Jose Conejo-Garcia | - | 2018 | Member of Scientific Advisory Board |
Marco L. Davila | - | 2018 | Member of Scientific Advisory Board |
Lewis H. Titterton | 78 | 2012 | Lead Independent Director |
Ian Hector Frazer | - | 2019 | Member of Scientific Advisory Board |
Emily Gottschalk | 62 | 2019 | Independent Director |
Hope S. Rugo | - | 2023 | Member of Breast Cancer Clinical Advisory Board |
Brian Czerniecki | - | 2023 | Member of Breast Cancer Clinical Advisory Board |
G. Thomas Budd | - | 2023 | Member of Breast Cancer Clinical Advisory Board |
Lisa H. Butterfield | - | 2023 | Member of Breast Cancer Clinical Advisory Board |
Brian Leyland-Jones | 73 | 2023 | Member of Breast Cancer Clinical Advisory Board |
Karen E. Knudsen | - | 2023 | Member of Cancer Business Advisory Board |
Robert E. Youle | - | 2023 | Member of Cancer Business Advisory Board |
Daniel P. Heist | - | 2023 | Member of Cancer Business Advisory Board |
Len Lichtenfeld | - | 2023 | Member of Cancer Business Advisory Board |
Scarlott K. Mueller | - | 2023 | Member of Cancer Business Advisory Board |
Michael T. Marquardt | - | 2023 | Member of Cancer Business Advisory Board |
Gary M. Reedy | - | 2023 | Member of Cancer Business Advisory Board |
Arnold M. Baskies | 74 | 2018 | Member of SAB & Breast Cancer Clinical Advisory Board, Co-Chair of CBAB and Independent Director |
Mark A. Goldberg | 69 | 2023 | Member of Cancer Business Advisory Board |
Pamela D. Garzone | 68 | 2021 | Chief Development Officer & Chair Breast Cancer Clinical Advisory Board |
Amit Kumar | 60 | 2012 | CEO, Chairman & Co-Chair of CBAB |
Sanjay Juneja | - | 2024 | Member of Cancer Business Advisory Board |
确定屏蔽%USER_NAME%?
如果屏蔽,您和%USER_NAME%都无法看到相互在Investing.com上发布的信息。
%USER_NAME%已成功添加至屏蔽列表
由于您刚刚取消屏蔽此人,因此必须等待48小时才能重新屏蔽。
您举报该评论的原因为:
谢谢您!
您的举报将会被发送到管理员进行审核